Cargando...
Extended Stability of Reconstituted Lyophilized Erwinia L-asparaginase in Vials
Background/Aim: L-Asparaginase (L-ASNase) is used as a tumor-inhibitory drug on paediatric acute lymphoblastic leukemia (ALL). ERW-ASNase is commercialised as a lyophilized powder stable only for 8 hours once reconstituted and, consequently, the leftover is usually discarded. The aim of this study w...
Gardado en:
| Publicado en: | In Vivo |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
International Institute of Anticancer Research
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7652457/ https://ncbi.nlm.nih.gov/pubmed/32871767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12055 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|